Sp384a
INTRODUCTION
Date
May 7, 2023
Explore related products in the following collection:
Society: AGA
The purpose of this session is to provide early career and trainee gastroenterologist with tips and strategies for having successful first few years in clinical practice. This session will discuss topics that are pertinent to all gastroenterologists including medical-legal issues (standardization of care, litigation, best practice), navigating difficult conversations, and tips that are specific to the various GI practice types. Attendees will receive high-yield and relevant information from respected AGA leaders in a format that is interactive and engaging.
The purpose of this session is to provide early career and trainee gastroenterologist with tips and strategies for having successful first few years in clinical practice. This session will discuss topics that are pertinent to all gastroenterologists including medical-legal issues (standardization of care, litigation, best practice), navigating difficult conversations, and tips that are specific to the various GI practice types. Attendees will receive high-yield and relevant information from respected AGA leaders in a format that is interactive and engaging.
Presenters
University of Colorado
Washington University School of Medicine/Barnes-Jewish Hospital
Tracks
Related Products
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
WRAP UP AND CLOSING
Attendees should attend this session to learn about practical examples of successful quality improvement projects for integration into their day to day work lives. This session will also provide guidance on how to develop a quality improvement project…
CLOSING
The purpose of this session is to provide early career and trainee gastroenterologist with tips and strategies for having successful first few years in clinical practice…
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
